Advisory Services Network, LLC Cytosorbents Corp Transaction History

Advisory Services Network, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.08 - $1.94 $2,376 - $4,268	2,200 New	2,200 $2,000
Q4 2022 Feb 13, 2023	BUY	$1.03 - $2.03 $2,266 - $4,466	2,200 New	2,200 $3,000
Q3 2021 Nov 05, 2021	SELL	$7.0 - $9.71 $51,660 - $71,659	-7,380 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.55 - $9.42 $55,719 - $69,519	7,380 New	7,380 $56,000
Q1 2021 May 24, 2021	SELL	$8.23 - $11.48 $60,737 - $84,722	-7,380 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$7.65 - $8.98 $2,295 - $2,694	-300 Reduced 3.91%	7,380 $59,000
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $56,601 - $88,627	7,680 New	7,680 $61,000
Q2 2020 Aug 10, 2020	SELL	$6.28 - $10.59 $35,670 - $60,151	-5,680 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.77 - $7.73 $9,764 - $20,020	2,590 Added 83.82%	5,680 $44,000
Q4 2019 Feb 04, 2020	SELL	$3.61 - $5.22 $1,480 - $2,140	-410 Reduced 11.71%	3,090 $12,000
Q2 2019 Aug 01, 2019	BUY	$5.92 - $7.78 $11,840 - $15,560	2,000 Added 133.33%	3,500 $0
Q1 2019 May 20, 2019	BUY	$6.82 - $8.56 $10,230 - $12,840	1,500 New	1,500 $11,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $57.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.